NITRIC-OXIDE PRODUCTION FROM MACROPHAGES IS REGULATED BY ARACHIDONIC-ACID METABOLITES

被引:46
作者
IMAI, Y [1 ]
KOLB, H [1 ]
BURKART, V [1 ]
机构
[1] UNIV DUSSELDORF,DIABET RES INST,HENNEKAMP 65,D-40225 DUSSELDORF,GERMANY
关键词
D O I
10.1006/bbrc.1993.2447
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In activated macrophages the inducible form of the enzyme nitric oxide (NO) synthase generates high amounts of the toxic mediator NO. After 20 h of treatment with LPS rat peritoneal macrophages release 12-16 nmol NO2-/105 cells which is detectable in the culture supernatant by the Griess reaction as a measure of NO formation. The addition of aminoguanidine (1 mM), a preferential inhibitor of the inducible NO-synthase, completely abolished NO2- accumulation. Incubation with indomethacin or acetyl-salicylic acid, preferential inhibitors of the cyclooxygenase pathway of the arachidonic acid metabolism, did not influence NO2- levels. Nordihydro-guaiaretic acid (50 μM), a preferential inhibitor of the lipoxygenase pathway, caused strong reduction of NO2- accumulation to 1.9 ± 0.3 nmol/200 μl. Simultaneous inhibition of cyclo- and lipoxygenase by BW755c resulted in an intermediate effect (7.3 ± 1.1 nmol/200 μl NO2-). These results show that the induction of NO production in activated macrophages is regulated by products of the lipoxygenase-pathway of the arachidonic acid metabolism. © 1993 Academic Press, Inc.
引用
收藏
页码:105 / 109
页数:5
相关论文
共 20 条
[1]  
BURKART V, 1993, CLIN EXP IMMUNOL, V93, P273
[2]   DIHYDROLIPOIC ACID PROTECTS PANCREATIC-ISLET CELLS FROM INFLAMMATORY ATTACK [J].
BURKART, V ;
KOIKE, T ;
BRENNER, HH ;
IMAI, Y ;
KOLB, H .
AGENTS AND ACTIONS, 1993, 38 (1-2) :60-65
[3]   AMINOGUANIDINE, A NOVEL INHIBITOR OF NITRIC-OXIDE FORMATION, PREVENTS DIABETIC VASCULAR DYSFUNCTION [J].
CORBETT, JA ;
TILTON, RG ;
CHANG, K ;
HASAN, KS ;
IDO, Y ;
WANG, JL ;
SWEETLAND, MA ;
LANCASTER, JR ;
WILLIAMSON, JR ;
MCDANIEL, ML .
DIABETES, 1992, 41 (04) :552-556
[4]   REGULATION OF NITRIC-OXIDE PRODUCTION BY STIMULATED RAT KUPFFER CELLS [J].
GAILLARD, T ;
MULSCH, A ;
BUSSE, R ;
KLEIN, H ;
DECKER, K .
PATHOBIOLOGY, 1991, 59 (04) :280-283
[5]   INVITRO EFFECT OF N-METHOXY-3-(3,5-DITERT-BUTYL-4-HYDROXY-BENZYLIDENE)-2-PYRROLIDONE (E-5110), A NOVEL NONSTEROIDAL ANTIINFLAMMATORY AGENT, ON GENERATION OF SOME INFLAMMATORY MEDIATORS [J].
KATAYAMA, K ;
SHIROTA, H ;
KOBAYASHI, S ;
TERATO, K ;
IKUTA, H ;
YAMATSU, I .
AGENTS AND ACTIONS, 1987, 21 (3-4) :269-271
[6]   NITRIC-OXIDE - A PATHOGENETIC FACTOR IN AUTOIMMUNITY [J].
KOLB, H ;
KOLBBACHOFEN, V .
IMMUNOLOGY TODAY, 1992, 13 (05) :157-159
[7]   ACTIVATED MACROPHAGES KILL PANCREATIC SYNGENEIC ISLET CELLS VIA ARGININE-DEPENDENT NITRIC-OXIDE GENERATION [J].
KRONCKE, KD ;
KOLBBACHOFEN, V ;
BERSCHICK, B ;
BURKART, V ;
KOLB, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 175 (03) :752-758
[8]   ROLE OF LIPOXYGENASE PRODUCTS IN MURINE PULMONARY GRANULOMA-FORMATION [J].
KUNKEL, SL ;
CHENSUE, SW ;
MOUTON, C ;
HIGASHI, GI .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (02) :514-524
[9]   MODULATION OF THE INDUCTION OF NITRIC-OXIDE SYNTHASE BY EICOSANOIDS IN THE MURINE MACROPHAGE CELL-LINE J774 [J].
MAROTTA, P ;
SAUTEBIN, L ;
DIROSA, M .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 (03) :640-641
[10]  
MONCADA S, 1991, PHARMACOL REV, V43, P109